MarketInOut Stock Screener Log In | Sign Up

SIGA Technologies Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 11/17/2026 16:00
SIGA Technologies Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization196.88 mln
Float41.13 mln
Earnings Date03/04/2027

EPS

0.01
Overpriced

P / E

273
Bubble territory

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-0.36
Highly suspicious

Relative Strength

23 / 100
Significantly lagging

Debt / Equity

0.00
Debt-free

Business Description

SIGA Technologies is a New York-based pharmaceutical company founded in 1995, specializing in medicines designed to protect public health against serious biological threats. Its primary product, TPOXX, is an antiviral treatment developed to combat smallpox, a disease caused by the variola virus. The company sells its products primarily within the United States.

Key Fundamentals

EPS0.01
P/E273
ROE0.39
RPS0.73
ROIC1.21
ROA0.34
EBITDA, mln-2.03
EV / EBITDA-55.60
EV / EBIT-42.87
Revenue, mln52.36
EV / Revenue2.16

Quote Details

Last 2.73
Change -0.12 (-4.21%)
Open 2.85
Volume 741,286
Turnover 2,023,711
Average Volume 546,642

Financial Ratios

Pre-Tax Profit Margin-5
Leverage Ratio1.06
Current Ratio24.57
Price / Book1.41
Price / Tangible Book1.41
Debt / Equity0.00
Price / Sales4.39
PEG Ratio3.37

Financial Strength

Altman Z-Score15.06
Piotroski F-Score 3 / 9
Beneish M-Score-0.36
Price to Intrinsic Value0.37
Price to Graham Number4.69
Shiller PE Ratio2.98
Short Ratio6.82
Short % of Float7.67

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -12.78% 15 / 100   
1 Month -13.06% 27 / 100   
2 Months -4.88% 58 / 100   
6 Months -37.53% 20 / 100   
1 Year -48.59% 19 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog